(The Exposé) Moderna is substantially expanding manufacturing capacity, despite low demand for their mRNA “poison.” according to Pharma and medical device research and development executive Sasha Latypova. In December 2022 the government announced that the UK had cemented a 10-year-partnership with Moderna in “major boost for vaccines and research” with a plan to build a “state-of-the-art vaccine manufacturing centre with the ability to produce up to 250 million vaccines a year.”
Apparently they are building them in many countries too, with much more capacity than they had for covid shots’ according to Sasha who claims that according to her inside source at Moderna, the new capacity is not for the flu vaccine. Her assessment is that “The ‘Blob is planning something “big”
Sasha Latypova has listed the countries that will be home to a Moderna manufacturing centre.
Canada:
“Moderna says construction of its new mRNA vaccine factory in Laval, Que. will begin later this year, with production expected to begin by the end of 2024. It will be the pharmaceutical giant’s first manufacturing facility outside the United States and cost an estimated $180 million to construct.”
Australia:
“US biotech company Moderna has reached an in-principle agreement to build an mRNA vaccine manufacturing facility in Victoria. It will become the first mRNA manufacturing facility in the Southern Hemisphere. Moderna expects to produce up to 100 million vaccine doses each year in Australia.”
UK:
“Expected to come online by 2025, the facility, also known as the MITC, will aim to supply the U.K. with mRNA vaccines for a “wide range” of respiratory diseases, according to Moderna. […] Last Summer, Moderna struck a preliminary deal with the U.K. to erect the MITC as part of an effort to shore up access to “rapid pandemic response capabilities.” At the time, Moderna said it was designing the facility to be activated “on an urgent basis.” The move falls under the U.K.’s “100 Days Mission,” which aims to blunt the force of future pandemics.”
Japan (pending government vaccine deal):
“On a vaccine diplomacy trip this week to Japan, Moderna CEO Stéphane Bancel told the Nikkei news outlet that the company would build a manufacturing facility there, contingent upon securing a long-term vaccine deal with the government.
The plant would be an end-to-end producer of shots for COVID, flu and any other vaccines the company might develop with its mRNA technology platform, Bancel told the publication, while referencing moves the company has made in Australia, Canada and England.”
China:
“SHANGHAI, Nov 28, 2023 (Reuters) – U.S. vaccine maker Moderna began construction of its first facility in China this month to manufacture mRNA medicines, the company said.”
Spain – expanded capacity at Rovi:
